vs
LAKELAND FINANCIAL CORP（LKFN）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是LAKELAND FINANCIAL CORP的1.1倍（$75.5M vs $69.7M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 0.7%）
总部位于美国佛罗里达州坦帕的非银行消费金融服务提供商，由伊恩·麦基奇尼于1989年创立，业务网络仅覆盖佛罗里达州，核心服务涵盖支票兑现、账单支付、预付费卡、发薪日贷款、免费汇票、网点ATM服务、电汇、公证、传真及邮政服务，目前运营近240家线下零售网点。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
LKFN vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$69.7M
两年增速更快
PBYI
近两年复合增速
0.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $69.7M | $75.5M |
| 净利润 | $26.5M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 38.0% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | 31.8% | — |
| 每股收益（稀释后） | $1.04 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LKFNPBYI
| Q1 26 | $69.7M | — | ||
| Q4 25 | $69.8M | $75.5M | ||
| Q3 25 | $69.0M | $54.5M | ||
| Q2 25 | $66.4M | $52.4M | ||
| Q1 25 | $63.8M | $46.0M | ||
| Q4 24 | $63.6M | $59.1M | ||
| Q3 24 | $61.2M | $80.5M | ||
| Q2 24 | $68.7M | $47.1M |
净利润LKFNPBYI
| Q1 26 | $26.5M | — | ||
| Q4 25 | $29.9M | — | ||
| Q3 25 | $26.4M | $8.8M | ||
| Q2 25 | $27.0M | $5.9M | ||
| Q1 25 | $20.1M | $3.0M | ||
| Q4 24 | $24.2M | — | ||
| Q3 24 | $23.3M | $20.3M | ||
| Q2 24 | $22.5M | $-4.5M |
毛利率LKFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率LKFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | 52.1% | 22.7% | ||
| Q3 25 | 46.4% | 17.6% | ||
| Q2 25 | 49.6% | 12.7% | ||
| Q1 25 | 38.0% | 8.7% | ||
| Q4 24 | 46.0% | 22.6% | ||
| Q3 24 | 45.3% | 27.4% | ||
| Q2 24 | 39.2% | -4.6% |
净利率LKFNPBYI
| Q1 26 | 38.0% | — | ||
| Q4 25 | 42.8% | — | ||
| Q3 25 | 38.3% | 16.2% | ||
| Q2 25 | 40.6% | 11.2% | ||
| Q1 25 | 31.5% | 6.5% | ||
| Q4 24 | 38.1% | — | ||
| Q3 24 | 38.1% | 25.2% | ||
| Q2 24 | 32.8% | -9.6% |
每股收益（稀释后）LKFNPBYI
| Q1 26 | $1.04 | — | ||
| Q4 25 | $1.16 | $0.26 | ||
| Q3 25 | $1.03 | $0.17 | ||
| Q2 25 | $1.04 | $0.12 | ||
| Q1 25 | $0.78 | $0.06 | ||
| Q4 24 | $0.94 | $0.40 | ||
| Q3 24 | $0.91 | $0.41 | ||
| Q2 24 | $0.87 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $85.6M | $97.5M |
| 总债务越低越好 | $183.6M | $22.7M |
| 股东权益账面价值 | $749.0M | $130.3M |
| 总资产 | $7.1B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.25× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资LKFNPBYI
| Q1 26 | $85.6M | — | ||
| Q4 25 | $141.3M | $97.5M | ||
| Q3 25 | $192.8M | $94.4M | ||
| Q2 25 | $310.2M | $96.0M | ||
| Q1 25 | $235.2M | $93.2M | ||
| Q4 24 | $168.2M | $101.0M | ||
| Q3 24 | $160.2M | $96.7M | ||
| Q2 24 | $121.2M | $96.8M |
总债务LKFNPBYI
| Q1 26 | $183.6M | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | $30.0M | $79.3M | ||
| Q2 24 | $55.0M | $90.7M |
股东权益LKFNPBYI
| Q1 26 | $749.0M | — | ||
| Q4 25 | $762.4M | $130.3M | ||
| Q3 25 | $747.4M | $115.3M | ||
| Q2 25 | $709.9M | $104.7M | ||
| Q1 25 | $694.4M | $97.1M | ||
| Q4 24 | $683.8M | $92.1M | ||
| Q3 24 | $699.1M | $71.1M | ||
| Q2 24 | $654.5M | $48.5M |
总资产LKFNPBYI
| Q1 26 | $7.1B | — | ||
| Q4 25 | $7.0B | $216.3M | ||
| Q3 25 | $6.9B | $202.9M | ||
| Q2 25 | $7.0B | $194.9M | ||
| Q1 25 | $6.9B | $196.2M | ||
| Q4 24 | $6.7B | $213.3M | ||
| Q3 24 | $6.6B | $220.7M | ||
| Q2 24 | $6.6B | $205.0M |
负债/权益比LKFNPBYI
| Q1 26 | 0.25× | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | 0.04× | 1.12× | ||
| Q2 24 | 0.08× | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流LKFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | $114.9M | $14.4M | ||
| Q3 25 | $36.1M | $9.7M | ||
| Q2 25 | $16.2M | $14.1M | ||
| Q1 25 | $28.9M | $3.6M | ||
| Q4 24 | $102.5M | $15.6M | ||
| Q3 24 | $18.0M | $11.0M | ||
| Q2 24 | $21.0M | $1.0M |
自由现金流LKFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | $103.8M | $14.4M | ||
| Q3 25 | $31.1M | $9.7M | ||
| Q2 25 | $14.1M | $14.1M | ||
| Q1 25 | $27.1M | $3.6M | ||
| Q4 24 | $93.9M | $15.6M | ||
| Q3 24 | $15.3M | $11.0M | ||
| Q2 24 | $18.6M | $1.0M |
自由现金流率LKFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | 148.7% | 19.1% | ||
| Q3 25 | 45.0% | 17.7% | ||
| Q2 25 | 21.2% | 26.8% | ||
| Q1 25 | 42.5% | 7.7% | ||
| Q4 24 | 147.6% | 26.4% | ||
| Q3 24 | 25.0% | 13.7% | ||
| Q2 24 | 27.0% | 2.1% |
资本支出强度LKFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | 15.9% | 0.0% | ||
| Q3 25 | 7.3% | 0.0% | ||
| Q2 25 | 3.2% | 0.0% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 13.6% | 0.0% | ||
| Q3 24 | 4.4% | 0.0% | ||
| Q2 24 | 3.5% | 0.0% |
现金转化率LKFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | 3.84× | — | ||
| Q3 25 | 1.37× | 1.10× | ||
| Q2 25 | 0.60× | 2.41× | ||
| Q1 25 | 1.44× | 1.21× | ||
| Q4 24 | 4.24× | — | ||
| Q3 24 | 0.77× | 0.54× | ||
| Q2 24 | 0.93× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LKFN
| Net Interest Income | $56.8M | 81% |
| Noninterest Income | $12.9M | 19% |
PBYI
暂无分部数据
